Clinical Trials · NCT02168062

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

TerminatedPhase 2Gonadorelin (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
University of California, San Francisco
Enrollment
57
Start date
Jun 2014
Locations
1 site, United States
Primary endpoint
Absolute Change in Percentage Body Fat Mass as Measured by Bioelectrical Impedance Analyzer (Randomized Cohort)
View Gonadorelin compound reference